1. Home
  2. ACR vs ENLV Comparison

ACR vs ENLV Comparison

Compare ACR & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACR

ACRES Commercial Realty Corp.

HOLD

Current Price

$14.04

Market Cap

146.1M

Sector

Real Estate

ML Signal

HOLD

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$1.25

Market Cap

149.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACR
ENLV
Founded
2005
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
146.1M
149.0M
IPO Year
2005
2014

Fundamental Metrics

Financial Performance
Metric
ACR
ENLV
Price
$14.04
$1.25
Analyst Decision
Buy
Buy
Analyst Count
1
2
Target Price
$24.50
$20.00
AVG Volume (30 Days)
26.6K
271.6K
Earning Date
04-30-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$79,946,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.68
$0.43
52 Week High
$24.61
$7.64

Technical Indicators

Market Signals
Indicator
ACR
ENLV
Relative Strength Index (RSI) 39.27 32.93
Support Level $13.83 $0.74
Resistance Level $15.20 $1.26
Average True Range (ATR) 0.49 0.16
MACD 0.07 -0.00
Stochastic Oscillator 44.08 11.27

Price Performance

Historical Comparison
ACR
ENLV

About ACR ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding, and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralized debt obligations, and private equity investments mainly issued by financial institutions.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Share on Social Networks: